Skip to content

Assess Specific Kinds of Children Challenges for Neurologic Devices Study

Assess Specific Kinds of Children Challenges for Neurologic Devices Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01191307
Enrollment
16
Registered
2010-08-30
Start date
2009-03-31
Completion date
2014-12-31
Last updated
2016-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Control, Epilepsy, Hearing Impaired (Partially), Hydrocephalus, Primary Dystonia

Keywords

Primary dystonia, Epilepsy, Hydrocephalus, Bladder Control, Deaf or Hearing Impaired

Brief summary

The ASK CHILDREN study is intended to aid in future development of various neurologic devices (i.e. neuroprostheses). The ASK CHILDREN study seeks to use study information obtained to identify more efficient strategies in the evaluation and review of neuroprostheses regulated by the Agency.

Detailed description

The ASK CHILDREN study is intended to aid in future development of various neurologic devices (i.e. neuroprostheses). The ASK CHILDREN study seeks to use study information obtained to identify more efficient strategies in the evaluation and review of neuroprostheses regulated by the Agency. Specific aims of the clinical study include: (1) Collecting qualitative and quantitative self-report clinical data (through interviews) from children undergoing treatment related to human factors, safety, usability, and adverse events in patients ages 7 to 15 years old implanted with a neuroprosthesis targeting the brain or spinal cord (at two 6 month intervals); and (2) Establish a science-based framework of recommendations based upon the data collected in the ASK CHILDREN Study to help develop more efficient strategies in evaluating pediatric neuroprostheses regulated by the Agency.

Interventions

None listed

Sponsors

Carlos Pena, PhD, MS
Lead SponsorFED

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

Primary Dystonia Inclusion Criteria * Between ages 7 and 15 years of age; * Implanted Medtronic Activa® Dystonia Therapy (approved or cleared by FDA for pediatric use). * Neurologic device implanted within the past 12 months; * Signed assent form document from the child * Signed permission form from the parent/guardian); and

Exclusion criteria

* Participation in another clinical investigation that could be jeopardized by participation in the current study; * Children with severe cognitive impairments (such as children with head injuries resulting in severe cognitive impairment) may be excluded because they may not be capable of self-reporting procedures. * Unable to comply with terms of the study Epilepsy Inclusion Criteria * Between ages 12 and 15 years of age; * Neurologic device implantation or surgical (in-hospital) adjustment within the past 12 months; * NeuroCybernetic Prosthesis (NCP®) System (approved or cleared by FDA for pediatric use; the NCP® System is approved for children in ages 12 years and older). * Signed assent form document from the child; and * Signed permission form from the parent/guardian). Epilepsy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026